News Releases

This section features all recent CSL Behring news releases. Click the tabs to select releases in your area of interest. Click Resources to find additional background material on CSL Behring.

All Releases
Bleeding Disorders
Hereditary Angioedema (HAE)
Fluid Management

All Releases

19 April 2017 Therapeutic Goods Administration Approves AFSTYLA® - CSL Behring’s Novel Recombinant Haemophilia A Treatment

Global biotherapeutics leader, CSL Behring today announced that the Australian Therapeutic Goods Administration (TGA) has approved AFSTYLA® [lonoctocog alfa].

> Read More
10 April 2017 Improving Access to Lifesaving Treatments for Bleeding Disorders in the Developing World

CSL Behring marks World Hemophilia Day by donating its bleeding disorders medicines to the World Federation of Hemophilia (WFH).

> Read More
05 April 2017 CSL Behring Presents Data on RAPID Trial Extension and Supports Alpha-1 International Research and Patient Conference

CSL Behring continues legacy of support for Alpha-1 Community with Global Research Conference and Patient Congress Sponsorship.

> Read More
31 March 2017 Jeffrey Modell Foundation to Open the First North African Network for Primary Immunodeficiencies

Like the other 253 sites that comprise the Jeffrey Modell Centers Network, the North African Network will offer advanced diagnostic evaluation to patients with a suspected primary immunodeficiency, a group of over 350 disorders arising from defects in the immune system carried by the genes and characterized by recurring infections that can be persistent, debilitating, chronic and life-threatening.

> Read More
29 March 2017 Patient Advocacy Organizations Continue to Develop Innovative Ways to Advocate for Patients

Patients are the most compelling advocates for access to care, which is why CSL Behring awards Local Empowerment for Advocacy Development (LEAD) grants to support advocacy work of rare disease patient groups. These groups tackle complex legislative and public policy issues and ensure patients’ voices are heard on Capitol Hill and in statehouses across the U.S.

> Read More
Page 5 of 7 First | Previous | Next | Last

LinkedIn Twitter Facebook Google+